1. Home
  2. TRST vs PHAR Comparison

TRST vs PHAR Comparison

Compare TRST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

HOLD

Current Price

$51.04

Market Cap

858.9M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.57

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRST
PHAR
Founded
1902
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.9M
1.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRST
PHAR
Price
$51.04
$13.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
70.9K
12.2K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.25%
N/A
EPS Growth
26.46
N/A
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$55.68
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$30.17
$9.54
52 Week High
$52.19
$21.34

Technical Indicators

Market Signals
Indicator
TRST
PHAR
Relative Strength Index (RSI) 65.72 45.18
Support Level $41.96 $12.98
Resistance Level N/A $17.80
Average True Range (ATR) 0.95 0.45
MACD 0.10 0.13
Stochastic Oscillator 69.09 96.89

Price Performance

Historical Comparison
TRST
PHAR

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: